Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-60,499
Closed -$478K 504
2024
Q3
$478K Sell
60,499
-108,829
-64% -$947K 0.03% 389
2024
Q2
$1.51M Buy
169,328
+44,636
+36% +$427K 0.09% 291
2024
Q1
$1.45M Sell
124,692
-1,032
-0.8% -$10.3K 0.1% 275
2023
Q4
$1.3M Sell
125,724
-175,694
-58% -$1.66M 0.16% 212
2023
Q3
$3.39M Buy
301,418
+141,718
+89% +$1.78M 0.42% 68
2023
Q2
$1.84M Buy
159,700
+6,491
+4% +$81K 0.23% 158
2023
Q1
$2.13M Sell
153,209
-105,889
-41% -$1.52M 0.3% 109
2022
Q4
$3.41M Buy
259,098
+147,873
+133% +$1.97M 0.56% 37
2022
Q3
$1.56M Buy
+111,225
New +$1.8M 0.3% 109

Other funds holding EHAB

CenterBook Partners's EHAB Position: Q4 2024 in Review

CenterBook Partners sold out of Enhabit (EHAB) in Q4 2024, closing a stake of 60,499 shares — an estimated $478K sold.

CenterBook Partners first reported a position in EHAB in Q3 2022 and held it in 9 quarters. The position peaked at $3.41M in Q4 2022. 165 funds tracked by Wall St. Rank hold EHAB as of Q4 2024.

  • CenterBook Partners reported no remaining Enhabit position as of Q4 2024 after selling out during the quarter.
  • CenterBook Partners sold 60,499 Enhabit shares in Q4 2024, an estimated $478K.
  • CenterBook Partners first reported a position in Enhabit in Q3 2022 and held it in 9 quarters.
  • CenterBook Partners's Enhabit position peaked at $3.41M in Q4 2022.
  • 165 funds tracked by Wall St. Rank held Enhabit as of Q4 2024.

Based on CenterBook Partners's 13F filing for Q4 2024, filed 13 Feb 2025.